Both cell types mediate persistent inflammation and fibrosis after AKI by secreting pro-fibrotic and pro-inflammatory cytokines such as MCP-1 and TNF-α leading to the development of CKD [26], [27], [42], [43], [44], [45], [46]. This evidence concerns the gene CCL2 and chronic kidney disease.